ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.19 Billion USD | 5.86% |
| 2022 | 2.07 Billion USD | 1.68% |
| 2021 | 2.03 Billion USD | 7.6% |
| 2020 | 1.89 Billion USD | 3.67% |
| 2019 | 1.82 Billion USD | 4.42% |
| 2018 | 1.74 Billion USD | -5.59% |
| 2017 | 1.85 Billion USD | 19.89% |
| 2016 | 1.54 Billion USD | -2.89% |
| 2015 | 1.59 Billion USD | -8.19% |
| 2014 | 1.73 Billion USD | 1.97% |
| 2013 | 1.7 Billion USD | 3.31% |
| 2012 | 1.64 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 556.7 Million USD | 0.0% |
| 2024 Q1 | 556.7 Million USD | -49.59% |
| 2023 Q4 | 1.1 Billion USD | 103.19% |
| 2023 FY | 2.19 Billion USD | 5.86% |
| 2023 Q1 | 527.75 Million USD | -50.15% |
| 2023 Q2 | 1.08 Billion USD | 105.86% |
| 2023 Q3 | 543.45 Million USD | -49.98% |
| 2022 FY | 2.07 Billion USD | 1.68% |
| 2022 Q4 | 1.05 Billion USD | 105.98% |
| 2022 Q3 | 514 Million USD | -47.59% |
| 2022 Q2 | 980.73 Million USD | 87.79% |
| 2022 Q1 | 522.25 Million USD | -48.9% |
| 2021 Q2 | 1 Billion USD | 98.95% |
| 2021 FY | 2.03 Billion USD | 7.6% |
| 2021 Q1 | 504 Million USD | -51.19% |
| 2021 Q3 | 515.15 Million USD | -48.62% |
| 2021 Q4 | 1.02 Billion USD | 98.41% |
| 2020 FY | 1.89 Billion USD | 3.67% |
| 2020 Q2 | 890.93 Million USD | 96.24% |
| 2020 Q3 | 493.15 Million USD | -44.65% |
| 2020 Q4 | 1.03 Billion USD | 109.37% |
| 2020 Q1 | 454 Million USD | -54.02% |
| 2019 Q1 | 444.45 Million USD | -2.4% |
| 2019 FY | 1.82 Billion USD | 4.42% |
| 2019 Q4 | 987.44 Million USD | 110.48% |
| 2019 Q3 | 469.15 Million USD | -46.35% |
| 2019 Q2 | 874.48 Million USD | 96.76% |
| 2018 Q2 | 460.65 Million USD | 0.0% |
| 2018 Q1 | 460.65 Million USD | -1.29% |
| 2018 FY | 1.74 Billion USD | -5.59% |
| 2018 Q4 | 455.4 Million USD | 0.0% |
| 2018 Q3 | 455.4 Million USD | -1.14% |
| 2017 Q3 | 466.65 Million USD | 12.27% |
| 2017 Q2 | 415.65 Million USD | 0.0% |
| 2017 Q1 | 415.65 Million USD | -3.27% |
| 2017 Q4 | 466.65 Million USD | 0.0% |
| 2017 FY | 1.85 Billion USD | 19.89% |
| 2016 Q3 | 429.7 Million USD | 1.06% |
| 2016 Q1 | 403.7 Million USD | -7.26% |
| 2016 Q4 | 429.7 Million USD | 0.0% |
| 2016 Q2 | 425.2 Million USD | 5.33% |
| 2016 FY | 1.54 Billion USD | -2.89% |
| 2015 FY | 1.59 Billion USD | -8.19% |
| 2015 Q4 | 435.3 Million USD | 5.5% |
| 2015 Q3 | 412.6 Million USD | 1.1% |
| 2015 Q2 | 408.1 Million USD | 3.47% |
| 2015 Q1 | 394.4 Million USD | -2.95% |
| 2014 Q1 | 429.3 Million USD | -6.82% |
| 2014 FY | 1.73 Billion USD | 1.97% |
| 2014 Q2 | 445 Million USD | 3.66% |
| 2014 Q4 | 406.4 Million USD | -10.33% |
| 2014 Q3 | 453.2 Million USD | 1.84% |
| 2013 Q3 | 435.8 Million USD | 1.87% |
| 2013 Q2 | 427.8 Million USD | 13.66% |
| 2013 FY | 1.7 Billion USD | 3.31% |
| 2013 Q4 | 460.7 Million USD | 5.71% |
| 2013 Q1 | 376.4 Million USD | -19.07% |
| 2012 Q4 | 465.1 Million USD | 14.47% |
| 2012 Q3 | 406.3 Million USD | 0.0% |
| 2012 FY | 1.64 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -68646.155% |
| Ansell Limited | 1.61 Billion USD | -35.492% |
| Ansell Limited | 1.61 Billion USD | -35.492% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -1088.219% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1624434.932% |
| Psykey, Inc. | 419.29 Thousand USD | -523158.022% |
| ConvaTec Group Plc | 2.14 Billion USD | -2.409% |
| Encision Inc. | 6.58 Million USD | -33213.923% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -120124.977% |
| LifePoint, Inc. | -18.5 Thousand USD | 11859644.07% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -32103.371% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -284098.919% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -222367.163% |
| Reflect Scientific, Inc. | 1.08 Million USD | -203020.634% |
| SmileDirectClub, Inc. | 470.74 Million USD | -366.075% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -17.226% |
| SheerVision, Inc. | 3.49 Million USD | -62596.784% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -158164.816% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -294361.987% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -2103805.385% |